Analysis of Clinical Factors in Olaparib-related Anemia Using Adverse Drug Event Reporting Databases
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16231
Abstract: Background/Aim: Anemia is one of the dose-limiting toxicities of olaparib. A global randomized controlled trial confirmed that anemia occurrence in Japanese was relatively high. The factors related to anemia in different nationalities remain unknown. Therefore,… read more here.
Keywords: factors olaparib; event; reporting; olaparib related ... See more keywords